Home / ASX / What’s wrong with Nanosonics?

What’s wrong with Nanosonics?

ASX

The Nanosonics Ltd (ASX: NAN) share price has sunk as much as 16% this morning after announcing it would renegotiate its contract with major distributor GE.

The business also expects to report revenue a 41% jump in revenue to $60.6 million for the first half when it releases its result on February 22.

Currently, the Nanosonics share price is down 8.53% to $4.61.

  • Keep up to date with the February 2022 reporting season calendar.

    Nanosonics designs and manufactures infection prevent equipment for hospitals and healthcare applications.

    Change up for final five months

    Nanosonics announced it would renegotiate its sales contract with GE for the remaining five months to June 30.

    Per the current sales model, GE purchases inventory from Nanosonics. Then it sells equipment such as capital devices and consumables to end-users.

    The revised model will see GE consume its existing inventory. Meanwhile, Nanosonics will take charge of inventory, shipping, installing and training.

    Nanosonics also transition all existing GE customers to its business for the sale of consumables.

    “During this transition, both companies will have a focus on ensuring a positive customer experience with no disruption in continuity of customer supply”

    Why change the contract?

    GE and Nanosonics are currently in the process of a new seller agreement from July 1 onwards.

    It is expected that the new agreement will involve Nanosonics taking a larger role in selling and distribution.

    Subsequently, GE wants to reduce its inventory of Nanosonics products before the contract is up.

    Otherwise, it could be left with excess inventory it’s unable to sell.

    Why did the Nanosonics share price drop 16%?

    As a result of the transition to a new sales model, Nanosonics expects a $13 million to 16 million fall in FY22 revenue.

    Consumables, which make up 80% of GE’s sales, will be unaffected.

    However, capital sales of devices are expected to be impacted, leading to the revenue revisal.

    While it’s a short term hit, the revenue drop has little to do with the underlying business. Rather, it’s a timing difference between purchases.

    Going forward, the Nanosonics share price will benefit from reducing its reliance on GE for sales support, opting instead to insource its sales team.

    The business will hire additional sales staff with a cost of $1 million in the second half.

    By the start of 2022, Nanosonics will have a direct North American sales force of 100 staff.

    “This sets up the organisation for ongoing success as we continue to grow our trophon franchise and plan to introduce new products to market”

    Information warning: The information in this article was published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169

    Lachlan Buur-Jensen

    Lachlan is a Bachelor of Commerce graduate with majors in Accounting and Finance from Monash University. He invests in companies with intense customer love, strongly aligned management teams and structural tailwinds. Lachlan is a big proponent of the eighth wonder of the world - compound returns, and its power in helping individuals reach financial freedom. Outside of investing, Lachlan enjoys supporting his AFL team - Essendon. Albeit, this can be frustrating at the best of times.




    Print Article

    Related
    Flight Centre hits bumpy patch – but longer-term outlook smoother

    A mild warning to the market from this global travel group in October had skittish investors bailing out. Those who held their nerve could enjoy a higher payout and share price if the travel industry picks up in 2025.

    Jamie Nemtsas | 18th Dec 2024 | More
    Raiz’s quarterly numbers finally start to excite the market

    The micro fund manager reported a solid performance with increasing funds under management, revenue and active customers. On the sharemarket, investors have been finding some appetite for this stock, but it’s a far cry from the buying frenzy that took it to $2 in 2021.

    Jamie Nemtsas | 18th Dec 2024 | More
    CSL has commercial ducks lined up for a healthy 2025

    The biotech giant is poised for a strong performance, building on a solid set of numbers posted in 2024. The wildcard remains a Donald Trump presidency and the potential for disruptive economic policies.

    Jamie Nemtsas | 11th Dec 2024 | More
    Popular